Keybank National Association Syndax Pharmaceuticals Inc Transaction History
Keybank National Association
- $28.1 Billion
- Q3 2025
A detailed history of Keybank National Association transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Keybank National Association holds 150,000 shares of SNDX stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$2.66 Million% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
255Shares Held
99.7MCall Options Held
1.22MPut Options Held
1.24M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$151 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$140 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$103 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$91.1 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$72.1 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...